Analytical Data
-
基因名
C10orf93
- Application
-
别名
CFAP46; C10orf123; C10orf124; C10orf92; C10orf93; TTC40Cilia- and flagella-associated Protein 46; Tetratricopeptide repeat Protein 40
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IYW2
-
表达区间
1-247aa
-
氨基酸序列
MDLVITQELARAESQQDAASLKKAYELIKSANLGKSEFDPSESFSPDLFVLCAEQALKMRQPEVSEDCIQMYFKVKAPITQFLGRAHLCRAQMCAPKSAENLEEFENCVTEYMKAINFAKGEPRYYFLVYNASVLYWQMVRPFLKPGYRHHLIPSLSQIINVLSQTEEEDKEWRAELMLELLECYLQAGRKEEAARFCSTAAPFIKSHVPQKYRQIFSVMVNQRIRNRDVRSNFLKSHCSENCVEIT
-
分子量
55 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C10orf93, also known as chromosome 10 open reading frame 93, is a gene of significant interest in various biomedical research fields due to its potential role in cellular processes and disease mechanisms. Initially identified through genomic studies, C10orf93 is believed to be involved in crucial biological functions, including cell signaling pathways and immune responses. Recent studies have linked alterations in the expression of C10orf93 to several health conditions, including autoimmune diseases and some cancers. Given the increasing relevance of protein-based therapies, researchers are focusing on the recombinant expression of C10orf93 to elucidate its structure-function relationships and explore its potential as a therapeutic target. The generation of recombinant C10orf93 protein allows for in-depth functional analyses, enabling the investigation of its interactions with other proteins and cellular components. Furthermore, understanding the post-translational modifications and molecular mechanisms underlying C10orf93 function could provide insights into disease pathology and identify novel biomarkers for early diagnosis. Overall, the study of C10orf93 recombinant proteins holds promise for advancing our knowledge of disease mechanisms and developing innovative therapeutic strategies.
